Guardant Health, Inc. annual net income for fiscal 2025 was -$416 million, an increase of 4.6% from -$436 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | ($416M) | ($436M) | ($479M) | ($655M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Net Income | ($112M) | ($128M) | ($93M) | ($100M) | ($95M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources